Top Stories

IGP Approves 3 New Area Commands for Ogun, commissions police ommand complex in Abeokuta

Army detains 2 soldiers over alleged theft in Dangote Refinery

Alleged fraud: EFCC withdraws operatives from  Bello’s house

Economic challenges, CBN and reconstruction policies, By Arize Nwobu

Delta relaunches SERVICOM as Oborevwori demands improved service from civil servants

Court threatens to adjourn Nnamdi Kanu’s trial indefinitely

NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria

COVAX

NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria

By Admin
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Oxford/AstraZeneca COVID-19 vaccine in Nigeria.
The Director-General of the agency, Dr. Mojisola Adeyeye made the announcement during a live briefing on Thursday.

She said that the vaccine can be stored at 2 to 8-degree centigrade.

According to the DG, there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.

NAFDAC
NAFDAC DG Prof. Mojisola Adeyeye

Dr. Adeyeye disclosed that the South African variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.

The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).